Two labs found the same molecule in 1998 and named it twice. One called it orexin, after the appetite it stirred. The other called it hypocretin, after where it sits. Both names lived. The lab test says hypocretin-1. The drug label says orexin. It answers to either, which is one way of admitting nobody has settled what it is for.
What it is for, mostly, is staying awake. The appetite is the smaller of its two jobs. That is the one it got named after first.
In 1999, two kinds of narcoleptic animal finished the sentence. The dogs had a broken receiver. The mice were missing the sender. The same collapse, arriving from opposite ends: one animal could not hear the signal, the other never made it.
In 2000, people with narcolepsy type 1 were tested. They are missing the sender. The cells that produce it are gone, and nobody can say exactly why. Their receivers were intact the entire time.
The body lost the signal. It never lost the ability to hear it.
For twenty-six years the medicine did not touch that. Stimulants, which shout at a system that cannot hear. Oxybates, which knock it out on purpose. Both manage the symptom. Neither addresses an absence, because you cannot hand someone the missing thing and expect it to land on a receiver that has been listening the whole time.
On August 5, 2026, the FDA approved oveporexton, an oral orexin receptor 2 agonist. It is not the signal. It is a hand on the bell: it goes to the receptor that was never damaged and rings it directly. The first drug approved to treat the cause.
Twenty-six years between a receiver proving it still worked and anyone managing to reach it. The mechanism was known. The target was known. What was missing was a molecule small and stubborn enough to get there. Not a failure of understanding. Just the ordinary distance between knowing where the door is and holding the key.
I keep coming back to the names. They named it for the appetite because the appetite was easy to see. The wakefulness was the point. We name things for what we can measure first, and the name outlives the measurement.